Submission Guidelines

• Authors must submit abstracts exclusively through the [official submission link/portal]. Submissions via email or other formats will not be accepted.

• Eligibility & Originality: Submitted abstracts must not have been published in any peer-reviewed journals, online publications, or presented at previous international congresses. Abstracts are acceptable if the original work is properly referenced; presentations at national meetings or by non-specialist collaborators may be considered at the Scientific Committee’s discretion.

• All abstracts must be submitted via the NSC Update 2026 abstract portal by 30 June 2026.

• Upon submission, an automated acknowledgement email will be sent to the author’s registered email address. If no acknowledgement is received within 24 hours, please contact nsc.update@nhghealth.com.sg

• Authors may revise and resubmit abstracts via the official portal until the 30 June 2026 deadline. No revisions will be accepted via email or other formats, and the latest submission received before the deadline will be considered the final version for review.

• Language: Abstracts and presentations must be written in UK English.

• Font Type and Size:  Times New Roman, size 12, with full justification.

• Title: Must not exceed 25 words. Be concise, descriptive, and directly reflective of the abstract’s core content. Write the entire title and author’s name in UPPERCASE letters. List the author’s name separately from their affiliated institutions, including the city and country, each on its own line. Only the presenting author’s name should be underlined. Exclude any academic degrees, professional titles, and full mailing addresses.

• Abbreviations: Use commonly accepted abbreviations where possible. Introduce any uncommon or specialised abbreviations by spelling out the full term first, followed by the abbreviation in brackets. Represent numbers using digits, except when they appear at the start of a sentence. Avoid commercial trade names, brand names, or promotional language (consistent with "Prohibited Content" below).

• Length Limit: The abstract body text is limited to 300 (Free Paper) or 350 words (Research Study) (excludes title, author names, institutional affiliations, and keywords).

• Structure: The abstract body must include the following bolded subheadings (each on a new line, followed by a colon and space; text begins immediately after):

  • Background: (Context, clinical relevance, or unmet need addressed by the work)

  • Objective: (Research question, hypothesis, or primary purpose of the study/case report)

  • Methods: (Study design, patient population, materials, procedures, or analytical approaches used)

  • Results: (Key quantifiable findings with relevant data/units; international metric system preferred)

  • Conclusions: (Interpretation of results, clinical implications, or future research directions)

• Prohibited Content: Do not include tables, graphs, images, or references in the abstract. The title, body, and presentation must be strictly unbiased and must NOT feature:

  • Submissions violating this rule will be withdrawn without prior notice.

  • Commercial product/device/company names, brand names, or trade names (use generic names only for drugs, devices, or products).

  • Promotional messages, corporate logos, or materials sponsored by commercial entities.

  • Keywords: Provide exactly two (2) keywords that align closely with the abstract’s core theme (e.g., “melasma,” “laser therapy,” “biostimulator,” “scar management”). Keywords should match the conference’s Abstract Topics (see below) to facilitate accurate categorisation and review.

• Authors: List full first names and surnames for all authors. Do not include academic degrees, professional titles, or honorifics (e.g., "Dr.," "Prof.," "MD").

• Presenting Author: Underline their name in the submission. A single Presenting Author may be listed as the presenter for up to 1 abstract submission maximum for each category (Free Paper and Study). Any additional abstracts must be presented by a different individual, who must also be listed as a co-author on the respective submission

• Corresponding Author: Bold their name in the submission (for official correspondence).

• Affiliations: For each author, list their department, institution, city, and country (e.g., "Department of Dermatology, National University Hospital, Singapore"). Ensure affiliations are accurate and complete to avoid publication errors.

• The presenting author is responsible for submitting the abstract, confirming co-author approval of the content, and complying with all conference guidelines.

• All presenting authors must register and pay the NSC Update in Dermatology and Venereology 2026 conference registration fee by 7 September 2026. Presenting authors who fail to register by this deadline will be excluded from the conference, and their abstracts will not be included in the program.

• Abstract submissions will be peer-reviewed by the Scientific Committee based on scientific rigor, clinical relevance, originality, and alignment with conference themes. Acceptance/rejection notifications will be sent to the presenting author via email.

• Submission of an abstract constitutes the authors’ agreement to the following:     

  • The presenting author will register, attend, and present the abstract in person at the conference (20–22 November 2026).

  • The work is based on ethical and valid scientific/clinical methods (in compliance with international research standards).

  • All authors have contributed significantly to the work and approved the final abstract content.

  • The accepted work will be presented as scheduled by the conference organizers.

  • Presenting authors who fail to register, attend, or present may be restricted from submitting abstracts to future NSC Update conferences.

Authors must select one category that best describes their submission during the online submission process:

1.             Poster Presentation (Case Report)

2.             Poster Presentation (Study)

3.             Oral Free Paper Presentation (Case Report)

4.             Oral Free Paper Presentation (Study)

Notes on Category Definitions

• Case Report: Focuses on individual patient cases (e.g., rare diseases, diagnostic dilemmas, therapeutic challenges, novel clinical observations) with clear clinical relevance to dermatology/venereology.

• Study: Encompasses original research (clinical trials, observational studies, cohort studies), systematic reviews, meta-analyses, or translational research with structured data collection and analysis.

Prizes will be awarded for the top poster or presentation in each category.

The selected abstract category (above) aligns with the presentation mode (oral or poster). Detailed technical requirements and logistics will be emailed to presenting authors after acceptance notifications.

Poster Presentation (Case Report / Study) – Terminal Viewing (No Live Presentation)

Eligibility Criteria: All healthcare professionals, students, and allied health workers are welcome to submit abstracts under this category.

Format Note: There will be no physical poster gallery on-site. Posters will be displayed exclusively in electronic form on digital terminals for viewing throughout the conference period.

• Format: PDF (high resolution, minimum 300 DPI; no password protection)

• Orientation: Portrait, 9:16 ratio

• Length: 1 page (single-sided; no supplementary attachments)

• File Size: Maximum 10MB

• Content Rules: Must comply with the same unbiased guidelines as abstracts (no commercial branding, promotional text, or excessive graphics). Ensure key findings, methods, and conclusions are visually clear for digital viewing.

Oral Free Paper Presentation (Case Report / Study)

Eligibility Criteria: All healthcare professionals and students may submit abstracts under this category. Priority for selection will be given to dermatology trainees of any nationality.

•                Format: PowerPoint

•                Orientation: Landscape, 16:9 ratio

•                File Size: Maximum 15MB

•                Duration: 10 minutes (presentation) + 5 minutes (Q&A)

•                Additional Requirements: A standardized PowerPoint template will be provided post-acceptance; authors must adhere to branding, font, and formatting guidelines to ensure consistency across presentations.

To further categorize submissions for review and attendee navigation, select 1–2 thematic topics that align with your abstract’s content (regardless of presentation category):

•                Acne & Acne Scarring

•                Vascular Disorders

•                Eczema and Urticaria

•                Pigmentary Disorders (Melasma, Lentigo, Vitiligo)

•                Autoimmune Dermatoses (Lupus, Psoriasis, Eczema etc)

•                Dermatologic Surgery

•                Cosmetic Dermatology

•                Hair and Nail Disorders

•                Sexually Transmitted Infections & Genital Dermatoses

•                Rare Dermatologic Diseases and Genodermatoses

•                Paediatric Dermatology

•                Drug Reactions

•                Telemedicine & AI in Dermatology

•                Skin Infections

•                Psychodermatology and Skin Health

After acceptance/rejection notifications, presenting authors will receive an email with:

• Confirmed abstract category and presentation mode

• Detailed technical specifications (e.g., file submission portal, PowerPoint template)

• Timeline for final presentation file submission (aligned with "Final Presentation Submission" in Important Dates)

• Onsite logistics (e.g., oral presentation slot, terminal viewing location, rehearsal schedules)

• Contact information for technical support or guideline clarifications

A limited number of scholarships are available for doctors based overseas coming to Singapore to attend the conference. The scholarship includes free registration for the main conference (excluding workshops) and S$1,000 to cover travel costs.

To be eligible, you must:

1) submit an abstract, which is subsequently selected for presentation

2) not be receiving other forms of sponsorships to attend NSC Update

The award is competitive. Not all applicants will be successful. You will be informed of the outcome together with abstract acceptance.

If you are keen to be considered for scholarship, please submit an abstract and indicate your desire in the abstract submission form. Do not register and make payment for the conference yet.